Mini Review
Published on 01 Jul 2022
Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.941437
- 4,914 views
- 7 citations
Type at least 3 characters
1,748 articles
Articles
Original Research
Published on 30 Jun 2022
Machine Learning–Based Overall Survival Prediction of Elderly Patients With Multiple Myeloma From Multicentre Real-Life Data
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.922039
- 3,171 views
- 7 citations
Original Research
Published on 30 Jun 2022
The Molecular Role of HIF1α Is Elucidated in Chronic Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.912942
- 4,047 views
- 4 citations
Mini Review
Published on 29 Jun 2022
Acute Myeloid Leukaemia Drives Metabolic Changes in the Bone Marrow Niche
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.924567
- 4,613 views
- 11 citations
Original Research
Published on 29 Jun 2022
p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.877495
- 2,109 views
- 6 citations
Original Research
Published on 29 Jun 2022
Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.897898
- 2,979 views
- 2 citations
Brief Research Report
Published on 29 Jun 2022
Bing-Neel Syndrome: Real-Life Experience in Personalized Diagnostic Approach and Treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.891052
- 7,924 views
- 4 citations
Brief Research Report
Published on 28 Jun 2022
TP53 Mutations Identified Using NGS Comprise the Overwhelming Majority of TP53 Disruptions in CLL: Results From a Multicentre Study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.909615
- 5,107 views
- 5 citations
Original Research
Published on 27 Jun 2022
A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.905490
- 4,176 views
Original Research
Published on 27 Jun 2022
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.890344
- 4,877 views
- 8 citations
Original Research
Published on 24 Jun 2022
Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.859618
- 2,327 views
- 1 citation
Review
Published on 24 Jun 2022
Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.925818
- 3,486 views
- 2 citations
Review
Published on 23 Jun 2022
Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.907584
- 4,181 views
- 6 citations
Review
Published on 23 Jun 2022
The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.931462
- 6,474 views
- 20 citations
Original Research
Published on 23 Jun 2022
Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.894419
- 2,756 views
- 7 citations
Review
Published on 23 Jun 2022
Arginase: Mechanisms and Clinical Application in Hematologic Malignancy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.905893
- 2,805 views
- 3 citations